AULT MILTON C III 13D and 13G filings for Alzamend Neuro, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-02 4:38 pm Purchase | 2024-01-31 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 315,804 40.300% | 122,000 (+62.95%) | Filing |
| 2024-01-25 5:21 pm Purchase | 2024-01-23 | 13D | Alzamend Neuro, Inc. ALZN | AULT MILTON C III | 193,804 29.400% | 193,804 (New Position) | Filing |